Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDDDD.L Share News (DDDD)

  • There is currently no data for DDDD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ceres Power eyes move to Main Market by mid-2022

Wed, 17th Mar 2021 18:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Ceres Power Holdings PLC - Horsham, West Sussex-based solid oxide fuel cell developer - Proposes placing and subscription to raise GBP180m million via PrimaryBid. Says the net proceeds will be used to accelerate its investment in the development and potential commercialisation of its solid-oxide electrolysis technology. This will help expand the company's presence in the green hydrogen production market. Intends to explore a move to the London Stock Exchange's Main Market by mid-2022.

----------

Young & Co's Brewery PLC - London-based pub operator - Expects to reopen about 140 of its managed pubs with outdoor spaces on or around April 12, within the government guidelines. Says the rest of its managed estate should open on or around May 17 with restricted indoor trading. Says if this reopening schedule proceeds as planned, the company expects to deliver a positive cash flow in May. Will not be paying any dividend for the current financial year to end March. Says any dividends during the upcoming financial year will not exceed GBP5 million in aggregate.

----------

GCM Resources PLC - mining and energy company focussed on the Phulbari coal and power project in north west Bangladesh - Says its development partners, have reaffirmed their commitment to progressing the project and have acknowledged that the global Covid-19 pandemic had impacted their ability to meet timelines over the past year. These partners include: China Nonferrous Metal Industry's Foreign Engineering and Construction Co Ltd and Power Construction Corp of China Ltd.

----------

Empire Metals Ltd - London-based resource exploration and development company - Says next phase to start at Eclipse gold project, located 55 kilometres north-east of Kalgoorlie, Western Australia. Says this phase will allow the company to map out the path to an initial open pit operation, along with improved definition of possible extensions to resources and the scope for additional future open pits. The phase will see reverse circulation drilling work at Eclipse followed by the diamond drilling in early April.

----------

4D Pharma PLC - Leeds-based live biotherapeutic products developer - Enters private share placement to raise USD24 million at USD1.53 each. Says the fundraising involves a broad range of institutional investors, strengthening our international investor base.

----------

Puma VCT 13 PLC - venture capital trust - Exercises GBP2.5m over-allotment facility on October subscription offer for shares of GBP0.0005 each in the company to raise GBP7.5 million, with an over-allotment facility to raise up to a further GBP2.5 million. Says following strong demand for the offer, the directors of the company have decided to exercise the over-allotment facility. The maximum the company can raise has now increased to GBP10 million.

----------

Serica Energy PLC - upstream oil & gas company - Spuds 23/16f-CDev1 development well at Columbus in UK North Sea. Says it plans to drill 23/16f-CDev1 development well to total depth of 17,600 feet. Expects production from Columbus in early fourth quarter of 2021. "I am delighted that drilling operations have commenced on the development well, which is a significant milestone for the company as Columbus is the first development project that Serica has undertaken as operator in the North Sea," says Chief Executive Mitch Flegg.

----------

Canadian Overseas Petroleum Ltd - oil and gas company focused on Sub-Saharan Africa - Completes Atomic Oil and Gas LLC acquisition.

----------

Altus Strategies PLC - Africa-focused mining royalty company - Announces the completion of a strategic review of high-grade Bikoula iron project in southern Cameroon. "We are pleased to report that independent consulting firm Mining Plus has completed a strategic economic review of the company's high grade Bikoula iron project in southern Cameroon. The project hosts a substantial colluvial iron weathered blanket, which rests above a primary iron deposit. The strategic review examined the processing, product specification and transportation options for Bikoula and will assist the company in advancing the project through next stages of development," Chief Executive Steven Poulton said.

----------

Residential Secure Income PLC - investor in affordable shared ownership, retirement and local authority housing - Acquires 68 income-generating shared ownership homes from Metropolitan Thames Valley Housing, for a total consideration of GBP5.1 million. Says the properties, located in a modern development in Swindon, comprise 53 apartments and 15 houses, in low-rise brick buildings. The acquisition brings the company's total shared ownership portfolio to 358 homes and will be funded through its GBP300 million, 45-year debt facility that was put in place in July last year.

----------

Fox Marble Holdings PLC - focused on marble quarrying and finishing in Kosovo and the Balkans region - Says Simon Nesbitt retained to act on its behalf in support of the ongoing case against. "The company and its advisors continue to strongly believe in the merits of Fox Marble's EUR195 million case against the Republic of Kosovo. We welcome the appointment of Mr Nesbitt QC to the legal team and look forward to the commencement of legal proceedings following the imminent nomination of the company's arbitration panellist," says Chief Executive Chris Gilbert. Fox Marble charges that the Kosovo government failed to protect Fox's rights over the Malesheve quarry, breaching its responsibilities toward foreign investors.

----------

DeepVerge PLC - York, England-based environmental & life science AI company - Announces initial data for ongoing Phase III clinical studies on the detection of SARS-CoV-2 on breath samples and identification of confirmed Covid-19 positive patients. "DeepVerge scientists have transformed its AI based water contamination detection system, developed over five years for e.coli, into the breath condensate Microtox BT unit. Having successfully completed Phase I testing on the Spike Protein and Phase II studies with SARS-CoV-2 virus in the safety of CL3 laboratories, the initial results of Phase III real-world clinical studies in Covid-19 patients have reached a major milestone with the demonstration that our Microtox BT can deliver results in under 60 seconds from breath samples," says Chief Executive Gerard Brandon.

----------

Hunters Property PLC - Yorkshire-based estate agent - Says court sanctions its takeover by Property Franchise. Reached agreement with Property Franchise in late January. Hunters has recommended the acquisition, which will be on the basis of 0.1655 Property Franchise shares plus 43.2 pence in cash for each Hunters share. The terms value each Hunters share at around 72.0p and the entire company at around GBP24.2 million.

----------

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
17 May 2022 11:07

IN BRIEF: 4D Pharma rises as asthma drug moves on to part B of trial

4D Pharma PLC - Leeds, England-based pharmaceutical company - Says part A of the phase I/II trial of MRx-4DP0004 for the treatment of asthma showed that a greater amount of patients receiving the drug than those receiving placebo experienced a reduction in asthma control questionnaire scores. Reports that a greater proportion of the MRx-4DP0004 group than the placebo group experienced a reduction in the total weekly use of rescue medication at all time points. Adds that 50% of patients receiving the drug experienced "clinically meaningful" improvements in asthma quality of life questionnaire scores. Says MRx-4DP0004 is progressing to part B of the trial. Plans to enrol asthma patients with more symptomatic disease. Expects this to give a greater scope for treatment effects to be observed.

Read more
1 Apr 2022 09:56

AIM WINNERS & LOSERS: Quiz shares in style as sales top expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
1 Apr 2022 08:11

IN BRIEF: 4D Pharma annual pretax loss widens, sees itself well-funded

4D Pharma PLC - Leeds, England-based pharmaceutical company - Posts widened pretax loss for 2021. Pretax loss stretches to GBP57.5 million from GBP30.3 million the year before.

Read more
23 Mar 2022 11:21

AIM WINNERS & LOSERS: RWS and James Cropper sink on profit warnings

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
23 Mar 2022 11:16

4d Pharma shares jump on positive results from cancer treatment study

(Alliance News) - 4d Pharma PLC shares soared on Wednesday after the company said that its phase I/II study for the combination of MRx0518 and Keytruda for the treatment of renal cell carcinoma showed positive results.

Read more
9 Mar 2022 19:26

IN BRIEF: 4D Pharma registers for potential ADS offering in US

4D Pharma PLC - Leeds, England-based pharmaceutical company - Files shelf registration statement to the US Securities & Exchange Commission following which the company may offer up to USD150.0 million of shares in the form of American Depositary Shares, with each ADS reflecting eight ordinary shares.

Read more
22 Feb 2022 21:57

TRADING UPDATES: Angling Direct ups revenue; Ceiba takes Omicron hit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
22 Feb 2022 09:55

4d Pharma gets FDA clearance for potential Parkinson's treatments

(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced on Tuesday that the United States Food and Drug Administration (FDA) has cleared investigational new drug applications for 'MRx0005' and 'MRx0029', for the treatment of Parkinson's disease.

Read more
27 Jan 2022 13:20

IN BRIEF: 4D Pharma sees encouraging results for MRx-4DP0004 in trial

IN BRIEF: 4D Pharma sees encouraging results for MRx-4DP0004 in trial

Read more
4 Jan 2022 10:32

IN BRIEF: 4d Pharma names John Doyle as new chief financial officer

IN BRIEF: 4d Pharma names John Doyle as new chief financial officer

Read more
13 Dec 2021 10:55

4D Pharma announces positive results in asthma treatment trials

4D Pharma announces positive results in asthma treatment trials

Read more
30 Sep 2021 11:05

4D Pharma pretax loss grows in first half after Spac merger costs

4D Pharma pretax loss grows in first half after Spac merger costs

Read more
29 Jul 2021 22:08

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

Read more
26 Jul 2021 16:23

EXECUTIVE CHANGES: Persimmon finance boss retires; Block fights Forest

EXECUTIVE CHANGES: Persimmon finance boss retires; Block fights Forest

Read more
4 Jun 2021 10:32

4D Pharma halts enrolment for Covid treatment trial, focuses on asthma

4D Pharma halts enrolment for Covid treatment trial, focuses on asthma

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.